ACEON (perindopril erbumine) · SYMPLMED PHARMS LLC
ACEON is FDA-approved to treat 3 conditions (same as PERINDOPRIL ERBUMINE).
Details
- Status
- Discontinued
- First Approved
- 1993-12-30
- Routes
- ORAL
- Dosage Forms
- TABLET
ACEON Approval History
What ACEON Treats
3 indicationsACEON is approved for 3 conditions since its original approval in 1993. These indications span multiple therapeutic areas including oncology, immunology, and more.
Same approved indications as PERINDOPRIL ERBUMINE (same active ingredient).
Clinical Trial Registry
2 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT07547878 RAPID-CKD | 026-271 | Ph 4 | not yet recruiting | Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) |
| NCT01556997 PATH results posted | X985400 | Ph 3 | completed | Perindopril Amlodipine for the Treatment of Hypertension |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ACEON FDA Label Details
Indications & Usage
FDA Label (PDF)ACEON is FDA-approved to treat 3 conditions — same approved indications as PERINDOPRIL ERBUMINE.
Track ACEON with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.